Google NewsCochlear Shares Building Momentum, Up 28% In Two Months: The Latest - thebull.com.au
Cochlear Shares Building Momentum, Up 28% In Two Months: The Latest thebull.com.au
COCHLEAR LIMITED ORDINARY (COH) News
Latest articles and price-sensitive announcements with AI sentiment classification.
KalkineWhy Is Cochlear (ASX:COH) Facing Its Biggest Challenge Yet?
Highlights Cochlear (ASX:COH) reduced its fiscal guidance following weaker market conditions. Hospital capacity constraints and softer patient referrals weighed on implant volumes. The company remains a leading name within Healthcare Stocks despite a difficult year. Cochlear has reset earnings expectations following weaker procedure volumes and hospital cons...
Why Is Cochlear (ASX:COH) Shaking the ASX 200 Healthcare Sector?
Highlights Cochlear (ASX:COH) has lowered its earnings outlook after weaker-than-expected implant demand. Hospital capacity constraints and softer patient referrals have weighed on procedure volumes. The downgrade has renewed attention across Australia's listed healthcare sector. Cochlear's revised earnings outlook has renewed attention on Australia's healthcare sector as hospital constraints an...
Why COH (ASX:COH) Shares Slumped After the Profit Guidance Shock?
Highlights Cochlear (ASX:COH) has faced one of its toughest years after a significant earnings guidance downgrade. Hospital capacity constraints, lower referral activity and regional disruptions delayed hearing implant procedures. The latest developments have placed Australia's Healthcare Stocks sector under renewed scrutiny. Cochlear's sharp guidance downgr...
Motley FoolDown 62%, should I buy Cochlear shares now?
Two leading analysts offer their outlooks for Cochlear’s beaten down share price. The post Down 62%, should I buy Cochlear shares now? appeared first on The Motley Fool Australia.
Is [ASX 200] Cochlear (ASX:COH) Facing Its Biggest Test Yet?
Highlights Cochlear (ASX:COH) delivered one of the largest profit guidance reductions in its listed history. The hearing implant leader has fallen to its lowest level in more than a decade as sentiment weakened. The downgrade has intensified scrutiny across the broader Healthcare Stocks sector. Cochlear faces heightened scrutiny after a major guidance downgrade triggered a sharp market reaction, raising questions about valuation, execution and growth while keeping the healthcare leader firmly...
Is Cochlear (ASX:COH) Facing Its Toughest Test Yet After a Deep Earnings Shock?
Highlights Cochlear shares remain under pressure following a significant earnings downgrade and weaker procedure volumes. Delayed surgeries and softer referral activity have weighed on demand across key markets. The hearing implant leader continues to navigate operational challenges while focusing on long-term healthcare needs. Cochlear faces renewed market scrutiny as delayed procedures, weaker referrals and softer demand affect performance, while its global healthcare franchise, insta...
What on earth's going on with Cochlear shares?
After wild swings, where does this healthcare share go? The post What on earth's going on with Cochlear shares? appeared first on The Motley Fool Australia.
Is Cochlear (ASX:COH) Facing a Healthcare Stock in ASX 200?
Highlights Cochlear (ASX:COH) remains under pressure after a significant profit downgrade rattled sentiment. Surgery delays and hospital constraints weigh on hearing implant demand across key markets. Investor focus shifts to recovery signals within Australia’s healthcare sector. Cochlear (ASX:COH) remains under pressure after a major earnings downgrade, with surgery delays and healthcare system constraints weighing on short-term performance within the ASX 200 healthcare sector. A...
Cochlear (ASX:COH) Shares Could Be 44% Below Fair Value After 2026 Guidance Cut - simplywall.st
Cochlear (ASX:COH) Shares Could Be 44% Below Fair Value After 2026 Guidance Cut simplywall.st
Is Cochlear (ASX:COH) Stock Recovering From Earlier Weakness? - Kalkine
Is Cochlear (ASX:COH) Stock Recovering From Earlier Weakness? Kalkine
Cochlear (ASX:COH): The Shock That Sent a Healthcare Giant Tumbling
Highlights Cochlear’s earnings downgrade triggered one of the sharpest declines seen among major Australian healthcare companies in recent years. Weaker patient demand, hospital capacity constraints and softer referral activity combined to pressure earnings expectations. The setback highlights the risks that come with paying premium valuations for high-quality growth businesses. The Australian share market has witnessed several unexpected turns this year, but few have been as dramatic a...
Why Cochlear (ASX:COH), Wesfarmers and NAB Keep Appearing on Long-Term Watchlists
Highlights Cochlear, Wesfarmers and National Australia Bank continue attracting attention for their established market positions. The three companies provide exposure to healthcare, consumer-focused operations and financial services. Strong business models and diversified earnings streams remain central to their long-term appeal. Cochlear, Wesfarmers and NAB continue drawing attention through established market positions, sector leadership and exposure to healthcare, consumer activity and fin...
Did Cochlear’s (ASX:COH) Guidance Cut Quietly Recast the Premium Medtech Growth Story? - simplywall.st
Did Cochlear’s (ASX:COH) Guidance Cut Quietly Recast the Premium Medtech Growth Story? simplywall.st
Cochlear's Comeback Story: Is This Healthcare Leader Finding Its Footing Again?
Highlights • Cochlear Limited (ASX:COH) has recovered from recent lows after a challenging period for the healthcare sector. • Regulatory delays in China weighed on sentiment and impacted first-half performance. • The company's global leadership in hearing implant technology continues to support its long-term growth narrative. Cochlear has begun recovering from a difficult period marked by regulatory delays and softer results, with investors assessing whether the healthcare leade...
Cochlear (ASX:COH) Guidance Cut Shakes ASX Healthcare
Highlights Cochlear (ASX:COH) delivered a major earnings downgrade, reshaping expectations across healthcare stocks. The guidance cut triggered a sharp sentiment reset across the ASX 200 healthcare sector. Premium valuations in ASX healthcare came under renewed scrutiny following the update. Cochlear’s earnings downgrade in 2026 reset expectations across ASX healthcare stocks, highlighting valuation sensitivity and shifting sentiment in premium medical device companies. Australian...
3 reasons to buy Cochlear shares in June
After a brutal sell-off, the stock may be gearing up for a recovery. The post 3 reasons to buy Cochlear shares in June appeared first on The Motley Fool Australia.
Kalkine Stock Analysis: Is Cochlear (ASX:COH) a Healthcare Stock Investors Are Watching Closely? - Kalkine
Kalkine Stock Analysis: Is Cochlear (ASX:COH) a Healthcare Stock Investors Are Watching Closely? Kalkine
Down 60%, are Cochlear shares now a bargain buy?
A leading analyst provides his outlook for Cochlear’s beaten-down shares. The post Down 60%, are Cochlear shares now a bargain buy? appeared first on The Motley Fool Australia.
How Do China Reimbursement Cuts Recast Cochlear’s (ASX:COH) Long-Term Margin Story? - simplywall.st
How Do China Reimbursement Cuts Recast Cochlear’s (ASX:COH) Long-Term Margin Story? simplywall.st
Cochlear (ASX:COH) Valuation Check As Earnings Guidance Downgrade Resets Market Expectations - simplywall.st
Cochlear (ASX:COH) Valuation Check As Earnings Guidance Downgrade Resets Market Expectations simplywall.st
ASXWhy everyone selling Cochlear shares right now could regret it in 3 years
Cochlear shares are down 65%. Here's why investors selling up right now could look back and wish they'd done the opposite. The post Why everyone selling Cochlear shares right now could regret it in 3 years appeared first on The Motley Fool Australia.
Cochlear’s Innovation Focus Remains in Spotlight Despite Operational Challenges
Highlights Cochlear continues advancing MRI-compatible hearing implant technology. Hospital capacity constraints and currency headwinds have weighed on recent performance. Long-term growth outlook remains tied to expanding demand for implantable hearing solutions. Cochlear Limited (ASX:COH) has recently attracted attention as investors assess the balance between ongoing product innovation and near-term operational challenges. The hearing implant specialist has faced pressure from hospital cap...
How Innovation Amid Earnings Pressures At Cochlear (ASX:COH) Has Changed Its Investment Story - simplywall.st
How Innovation Amid Earnings Pressures At Cochlear (ASX:COH) Has Changed Its Investment Story simplywall.st
Why Are Healthcare Stocks (ASX:COH, ASX:RMD) Holding ASX 200 Strong?
Highlights Healthcare Stocks on the ASX reflect strong defensive characteristics during volatile market phases. S&P/ASX Health Care Index remains a key benchmark tracking sector-wide activity. Companies such as CSL Limited, Resmed, and Cochlear remain central to sector developments. Healthcare Stocks on the ASX highlight defensive sector characteristics, with stable demand, essential services, and key companies shaping market activity across global healthcare industries. The healthc...
Cochlear Strengthens Healthcare Market Presence Amid Industry Focus
Highlights Cochlear continues expanding its global hearing solutions network Healthcare demand supports long-term sector resilience Market valuation trends keep Cochlear under investor focus Cochlear continues attracting market attention as demand for healthcare innovation grows across global markets. The company’s strong industry position, expanding reach, and healthcare sector resilience remain key discussion points. Cochlear Ltd (ASX:COH) continues to attract strong market atte...
Why Cochlear Is Quietly Regaining Market Attention
Highlights Cochlear continues drawing attention as healthcare stocks regain focus across the Australian market. The hearing implant specialist benefits from long-term healthcare demand and global ageing trends. Investors remain focused on valuation levels and defensive healthcare sector characteristics. Cochlear continues attracting investor attention as healthcare stocks regain momentum through defensive demand trends, ageing population exposure, and long-term medical technology growth theme...
Why Cochlear Shares Remain Under Pressure After Profit Shock
Highlights Cochlear faces renewed market scrutiny following a major FY26 profit guidance cut Hospital capacity constraints and softer implant demand continue weighing on sentiment The hearing implant leader remains under focus as traders watch whether shares stabilise near key levels Cochlear remains under pressure after its FY26 earnings downgrade as markets focus on implant demand recovery, hospital capacity conditions, and healthcare sector stability. Healthcare giant Cochlear Ltd (ASX:COH...
Cochlear shares crashed in April, but is a comeback looming?
This ASX 200 healthcare stock is caught between short-term pain and long-term potential. The post Cochlear shares crashed in April, but is a comeback looming? appeared first on The Motley Fool Australia.
Cochlear (ASX:COH) Valuation Check After Guidance Cut And Global Demand Challenges - simplywall.st
Cochlear (ASX:COH) Valuation Check After Guidance Cut And Global Demand Challenges simplywall.st
Cochlear cuts FY26 earnings outlook amid softer sales
Cochlear reduces its FY26 earnings guidance amid softer implant sales, ongoing challenges in key markets, and a focus on long-term growth. The post Cochlear cuts FY26 earnings outlook amid softer sales appeared first on The Motley Fool Australia.
Trading update and reduction to FY26 earnings guidance
earnings announcement
Cochlear (ASX:COH) Gains Attention Across ASX 50 on Implant Tech
Highlights Medical device innovation remains central to hearing implant technology. Global distribution network supports advanced auditory solutions across many regions. Developments highlight the evolving role of hearing restoration technologies. Cochlear Limited activity within the ASX 50 highlights implantable hearing technology, global healthcare distribution networks, and ongoing advancements in medical device innovation. Medical technology companies represent a vital segment of the heal...